Actavis Trademark Details
Word Mark | Actavis |
---|---|
Status | Alive 731 — Second Extension - Granted |
Serial Number | 85773902 |
---|---|
Status Date | Monday, August 1, 2016 |
Filing Date | Monday, August 1, 2016 |
Attorney | Gabrielle S. Roth |
Correspondent
GABRIELLE S ROTH
SUGHRUE MION PLLC
2100 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037-3213
SUGHRUE MION PLLC
2100 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037-3213
Case File Statements
Indication of Colors | The color(s) green and blue is/are claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of the word "ACTAVIS" displayed in the color green, below the letters "a" and "w", which appear in an intertwined, fanciful lettering style displayed in the colors green and blue that resembles a horizontal zig-zag line or a coil. |
Goods & Services | Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry |
Goods & Services | Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth |
Goods & Services | Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators |
Goods & Services | Education services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development |
Goods & Services | Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Wednesday, November 14, 2012 |
Primary Code | 001 |
International Class Codes |
003
|
---|---|
U.S. Class Codes | 001, 004, 006, 050, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, November 14, 2012 |
Primary Code | 003 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, November 14, 2012 |
Primary Code | 005 |
International Class Codes |
041
|
---|---|
U.S. Class Codes | 100, 101, 107 |
Status | 6 — Active |
Status Date | Wednesday, November 14, 2012 |
Primary Code | 041 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Wednesday, November 14, 2012 |
Primary Code | 042 |
Trademark Timeline
-
Nov 07 2012Trademark application filed with USPTO
-
Nov 10 2012New Application Entered In Tram
-
Nov 14 2012New Application Office Supplied Data Entered In Tram
-
Nov 15 2012Notice of Design Search Code Mailed
-
Nov 28 2012Assigned To Examiner
-
Dec 03 2012Notification of Examiner's Amendment/priority Action E-Mailed
-
Dec 03 2012Examiner's Amendment/priority Action E-Mailed
-
Dec 03 2012Combined Examiner's Amendment/priority Action Automatic Entry
-
Dec 03 2012Examiners Amendment And/or Priority Action - Completed
-
Feb 04 2013Teas/email Correspondence Entered
-
Feb 04 2013Correspondence Received In Law Office
-
Feb 04 2013Teas Response To Office Action Received
-
Feb 05 2013Notification of Letter of Suspension E-Mailed
-
Feb 05 2013Letter of Suspension E-Mailed
-
Feb 05 2013Suspension Letter Written
-
Mar 20 2013Automatic Update of Assignment of Ownership
-
May 30 2013Attorney Revoked And/or Appointed
-
May 30 2013Teas Revoke/appoint Attorney Received
-
Jun 13 2013Teas/email Correspondence Entered
-
Jun 13 2013Correspondence Received In Law Office
-
Jun 13 2013Teas Response To Suspension Inquiry Received
-
Jun 14 2013Approved For Pub - Principal Register
-
Jul 01 2013Assigned To Examiner
-
Jul 02 2013Assigned To Lie
-
Jul 03 2013Law Office Publication Review Completed
-
Jul 17 2013Notification of Notice of Publication E-Mailed
-
Aug 06 2013Official Gazette Publication Confirmation E-Mailed
-
Aug 06 2013Published For Opposition
-
Aug 16 2013Extension of Time To Oppose Received
-
Jan 30 2014Opposition Instituted No. 999999
-
Feb 10 2015Ttab Release Case To Trademarks
-
Feb 10 2015Opposition Terminated No. 999999
-
Feb 10 2015Opposition Dismissed No. 999999
-
Jul 07 2015Noa E-Mailed - Sou Required From Applicant
-
Nov 23 2015Extension 1 Granted
-
Nov 23 2015Extension 1 Filed
-
Nov 23 2015Teas Extension Received
-
Nov 25 2015Notice of Approval of Extension Request E-Mailed
-
Jun 28 2016Extension 2 Filed
-
Jun 28 2016Teas Extension Received
-
Jul 29 2016Case Assigned To Intent To Use Paralegal
-
Aug 01 2016Extension 2 Granted
-
Aug 02 2016Notice of Approval of Extension Request E-Mailed